{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:30:06Z","timestamp":1754195406230},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s10557-004-6223-1","type":"journal-article","created":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T19:22:23Z","timestamp":1110914543000},"page":"461-468","source":"Crossref","is-referenced-by-count":16,"title":["Time-Domain Evaluation of Cyclosporine Interaction with Hemodynamic Variability in Rats"],"prefix":"10.1007","volume":"18","author":[{"given":"Amal G.","family":"Omar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"El-Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"499","volume-title":"Cardiology Clinics, Vol. 10, No. 3.","author":"Z Ori","year":"1992","unstructured":"Ori Z, Monir G, Weiss J, Sayhouni X, Singer DH. Heart rate variability: Frequency domain analysis. In: Kennedy HL, ed. Cardiology Clinics, Vol. 10, No. 3. Philadelphia: W.B. Saunders Co., 1992:499?533."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10641969809053219","volume":"20","author":"N. Japundzic-Zigon","year":"1998","unstructured":"Japundzic-Zigon N. Physiological mechanisms in regulation of blood pressure fast frequency variations. Clin Exp Hypertens 1998;20:359?388.","journal-title":"Clin Exp Hypertens"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/0002-8703(94)90059-0","volume":"127","author":"PK Stein","year":"1994","unstructured":"Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: A measure of cardiac autonomic tone. Am Heart J 1994;127:1376?1381.","journal-title":"Am Heart J"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.19.8.1979","volume":"19","author":"HV Huikuri","year":"1999","unstructured":"Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979?1985.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"CR5","first-page":"312","volume-title":"Cardiac Electrophysiology From Cell to Bedside","author":"DP Zipes","year":"1990","unstructured":"Zipes DP, Miyazaki T. The autonomic nervous system and the heart: Basis for understanding interactions and effects on arrhythmia development. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside Philadelphia, PA: Saunders, 1990:312?330."},{"key":"CR6","first-page":"H1754","volume":"273","author":"A Sgoifo","year":"1997","unstructured":"Sgoifo A, de Boer SF, Westenbroek C, et al. Incidence of arrhythmias and heart rate variability in wild-type rats exposed to social stress. Am J Physiol 1997;273:H1754?1760.","journal-title":"Am J Physiol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0002-9149(90)90585-O","volume":"66","author":"VE Friedwald","year":"1990","unstructured":"Friedwald, VE, Spence DW. Sudden death associated with exercise: The risk-benefit issue. Am J Cardiol 1990;66:183?188.","journal-title":"Am J Cardiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1152\/japplphysiol.00874.2001","volume":"92","author":"GE Billman","year":"2002","unstructured":"Billman GE. Aerobic exercise conditioning: A nonpharmacological antiarrhythmic intervention. J Appl Physiol 2002;92:446?454.","journal-title":"J Appl Physiol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.HYP.36.5.894","volume":"36","author":"G Mancia","year":"2000","unstructured":"Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000;36:894?900.","journal-title":"Hypertension"},{"issue":"suppl 4","key":"CR10","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00004872-199512002-00005","volume":"13","author":"G Parati","year":"1995","unstructured":"Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens 1995;13(suppl 4):S27?S34.","journal-title":"J Hypertens"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005344-199708000-00014","volume":"30","author":"K Chaouche-Teyara","year":"1997","unstructured":"Chaouche-Teyara K, Lacolley P, Challande P, et al. Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol 1997;30:241?244.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 12","key":"CR12","first-page":"S142","volume":"10","author":"M Timio","year":"1987","unstructured":"Timio M, Venanzi S, Gentili S, Ronconi M, Del Re G, Del Vita M. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: Relationship between echocardiographic findings, blood pressure, and urinary catecholamines. J Cardiovasc Pharmacol 1987;10 (Suppl 12):S142?S146.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/14728214.8.1.47","volume":"8","author":"JM Kovarik","year":"2003","unstructured":"Kovarik JM, Burtin P. Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opin Emerg Drugs 2003;8:47?62.","journal-title":"Expert Opin Emerg Drugs"},{"key":"CR14","first-page":"423","volume":"41","author":"J. Mason","year":"1990","unstructured":"Mason J. Pharmacology of cyclosporine (Sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 1990;41:423?434.","journal-title":"Pharmacol Rev"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM198112033052306","volume":"305","author":"H Shulman","year":"1981","unstructured":"Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: Glomerular thromboses and tubular injury. N Engl J Med 1981;305:1392?1395.","journal-title":"N Engl J Med"},{"key":"CR16","first-page":"405","volume":"34","author":"FA LoVecchio","year":"2000","unstructured":"LoVecchio FA, Goltz HR. Atrial fibrillation following acute overdose with oral cyclosporine. Ann Pharmacother 2000;34:405.","journal-title":"Ann Pharmacother"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"H425","DOI":"10.1152\/ajpheart.00546.2002","volume":"284","author":"LM Semeniuk","year":"2003","unstructured":"Semeniuk LM, Severson DL, Kryski AJ, Swirp SL, Molkentin JD, Duff HJ. Time-dependent systolic and diastolic function in mice overexpressing calcineurin. Am J Physiol Heart Circ Physiol 2003;284:H425?H430.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"CR18","first-page":"980","volume":"16","author":"WJ Ko","year":"1997","unstructured":"Ko WJ, Lin FL, Wang SS, Chu SH. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. J Heart Lung Transplant 1997;16:980?982.","journal-title":"J Heart Lung Transplant"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/jlts.2002.34381","volume":"8","author":"G Therapondos","year":"2002","unstructured":"Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl 2002;8:690?700.","journal-title":"Liver Transpl"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00007890-200209270-00015","volume":"74","author":"CA Roberts","year":"2002","unstructured":"Roberts CA, Stern DL, Radio SJ. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Transplantation 2002;74:817?821.","journal-title":"Transplantation"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/cvr\/27.10.1845","volume":"27","author":"HS Banijamali","year":"1993","unstructured":"Banijamali HS, ter Keurs MH, Paul LC, ter Keurs HE. Excitation-contraction coupling in rat heart: Influence of cyclosporin A. Cardiovasc Res 1993;27:1845?1854.","journal-title":"Cardiovasc Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0008-6363(97)00256-3","volume":"37","author":"AD Wickenden","year":"1998","unstructured":"Wickenden AD, Kaprielian R, Kassiri Z, et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res 1998;37:312?323.","journal-title":"Cardiovasc Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-5273(98)00368-4","volume":"68","author":"U Gerhardt","year":"1999","unstructured":"Gerhardt U, Riedasch M, Hohage H. Cyclosporine A modulates baroreceptor function in kidney transplant recipients. Int J Cardiol 1999;68:203?208.","journal-title":"Int J Cardiol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.301.1.346","volume":"301","author":"MM El-Mas","year":"2002","unstructured":"El-Mas MM, Afify EA, Omar AG, Sharabi FM. Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J Pharmacol Exp Ther 2002;301:346?354.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1139\/y02-084","volume":"80","author":"MM El-Mas","year":"2002","unstructured":"El-Mas MM, Afify EA, Omar AG, Sharabi FM. Cyclosporine attenuates the autonomic modulation of reflex chronotropic responses in conscious rats. Can J Physiol Pharmacol 2002;80:766?776.","journal-title":"Can J Physiol Pharmacol"},{"key":"CR26","first-page":"157","volume":"262","author":"MM El-Mas","year":"1992","unstructured":"El-Mas MM, Abdel-Rahman AA. Role of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate in conscious rats. J Pharmacol Exp Ther 1992;262:157?165.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1530-0277.1997.tb03723.x","volume":"21","author":"MM El-Mas","year":"1997","unstructured":"El-Mas MM, Abdel-Rahman AA. Contrasting effects of urethane, ketamine, and thiopental anesthesia on ethanol-clonidine hemodynamic interaction. Alcohol Exp Clin Res 1997;21:19?27.","journal-title":"Alcohol Exp Clin Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00005344-199806000-00010","volume":"31","author":"MM El-Mas","year":"1998","unstructured":"El-Mas MM. Facilitation of reflex bradycardia does not contribute to the enhanced hypotensive effect of clonidine in aortic barodenervated rats. J Cardiovasc Pharmacol 1998;31:869?875.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR29","first-page":"H515","volume":"238","author":"TG Coleman","year":"1980","unstructured":"Coleman TG. Arterial baroreflex control of heart rate in the conscious rat. Am J Physiol 1980;238:H515?H520.","journal-title":"Am J Physiol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00005344-200111000-00012","volume":"38","author":"MM El-Mas","year":"2001","unstructured":"El-Mas MM, Afify EA, Mohy El-Din MM, Omar AG, Sharabi FM. Testosterone facilitates the baroreceptor control of reflex bradycardia: Role of cardiac sympathetic and parasympathetic components. J Cardiovasc Pharmacol 2001;38:754?763.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/jpet.102.048355","volume":"306","author":"MM El-Mas","year":"2003","unstructured":"El-Mas MM, Abdel-Rahman AA. Effects of chronic ethanol feeding on clonidine-evoked reductions in blood pressure, heart rate, and their variability: Time-domain analyses. J Pharmacol Exp Ther 2003;306:271?278.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00005344-200405000-00001","volume":"43","author":"MM El-Mas","year":"2004","unstructured":"El-Mas MM, Abdel-Rahman AA. Effects of long-term ovariectomy and estrogen replacement on clonidine-evoked reductions in blood pressure and hemodynamic variability. J Cardiovasc Pharmacol 2004;43:607?615.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR33","first-page":"944","volume":"292","author":"MM El-Mas","year":"2000","unstructured":"El-Mas MM, Abdel-Rahman AA. Radiotelemetric evaluation of the hemodynamic effects of long-term ethanol in spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther 2000;292:944?951.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0031-9384(02)00698-4","volume":"76","author":"EK Visser","year":"2002","unstructured":"Visser EK, van Reenen CG, van der Werf JT, et al. Heart rate and heart rate variability during a novel object test and a handling test in young horses. Physiol Behav 2002;76:289?296.","journal-title":"Physiol Behav"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.HYP.29.2.576","volume":"29","author":"M Ryuzaki","year":"1997","unstructured":"Ryuzaki M, Stahl LK, Lyson T, Victor RG, Bishop VS. Sympathoexcitatory response to cyclosporin A and baroreflex resetting. Hypertension 1997;29:576?582.","journal-title":"Hypertension"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.82.23.8222","volume":"82","author":"NG Moss","year":"1985","unstructured":"Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985;82:8222?8226.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199009133231101","volume":"323","author":"U Scherrer","year":"1990","unstructured":"Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after transplantation. N Engl J Med 1990;323:693?699.","journal-title":"N Engl J Med"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-198705000-00022","volume":"43","author":"H Xue","year":"1987","unstructured":"Xue H, Bukoski RD, McCarron DA, Bennett MW. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 1987;43:715?718.","journal-title":"Transplantation"},{"key":"CR39","first-page":"1105","volume":"250","author":"JF Gerkens","year":"1989","unstructured":"Gerkens JF. Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators. J Pharmacol Exp Ther 1989;250:1105?1112.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0272-6386(12)81015-8","volume":"23","author":"JJ Curtis","year":"1994","unstructured":"Curtis JJ. Hypertension following kidney transplantation. Am J Kidney Dis 1994;23:471?475.","journal-title":"Am J Kidney Dis"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0895-7061(00)00288-0","volume":"13","author":"W Zhang","year":"2000","unstructured":"Zhang W, Victor RG. Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 2000;13:999? 1004.","journal-title":"Am J Hypertens"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.170160397","volume":"97","author":"W Zhang","year":"2000","unstructured":"Zhang W, Li JL, Hosaka M, et al. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci USA 2000;97:9765?9770.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1471-4159.1996.66010099.x","volume":"66","author":"G Marcaida","year":"1996","unstructured":"Marcaida G, Kosenko E, Minana MD, Grisolia S, Felipo V. Glutamate induces a calcineurin-mediated dephosphorylation of Na+,K(+)-ATPase that results in its activation in cerebellar neurons in culture. J Neurochem 1996;66:99?104.","journal-title":"J Neurochem"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0301-0082(90)90036-G","volume":"35","author":"M Kumada","year":"1990","unstructured":"Kumada M, Terui N, Kuwaki T. Arterial baroreceptor reflex: Its central and peripheral neural mechanisms. Prog Neurobiol 1990;35:331?361.","journal-title":"Prog Neurobiol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(97)01433-9","volume":"786","author":"M. Hay","year":"1998","unstructured":"Hay M. Cyclosporine A modulation of Ca++ activated K+ channels in cardiac sensory afferent neurons. Brain Res 1998;786:243?247.","journal-title":"Brain Res"},{"key":"CR46","first-page":"H1231","volume":"261","author":"JP Saul","year":"1991","unstructured":"Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function analysis of the circulation: Unique insights into cardiovascular regulation. Am J Physiol 1991;261:H1231?H1245.","journal-title":"Am J Physiol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1838(90)90132-3","volume":"30","author":"N Japundzic","year":"1990","unstructured":"Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: Effects of autonomic blockers. J Auton Nerv Syst 1990;30:91?100.","journal-title":"J Auton Nerv Syst"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-004-6223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-004-6223-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-004-6223-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:27:53Z","timestamp":1559237273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-004-6223-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["6223"],"URL":"https:\/\/doi.org\/10.1007\/s10557-004-6223-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}